This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • Updated Cochrane Review: Corticosteroids for Managing Tuberculous Meningitis
    The Cochrane Infectious Diseases Group (CIDG) has carried out a review update to evaluate the effects of corticosteroids being used alongside anti-tuberculosis medication to treat people suffering from tuberculous meningitis. Tuberculous meningitis is a serious form of ...More
    May 3, 2016 Posted in News
  • Tuberculosis Bacteria Build 'Edible' Havens in Immune Cells
    Bacteria that cause tuberculosis trick immune cells meant to destroy them into hiding and feeding them instead. This is the result of a study led by researchers from NYU Langone Medical Center and published online April 18 in Nature Immunology. The study results revolve ...More
    April 19, 2016 Posted in News
  • Tuberculosis Elimination in Europe
    New data released by the European Centre for Disease Prevention and Control (ECDC) and WHO/Europe ahead of World TB Day show that an estimated 340,000 Europeans developed tuberculosis (TB) in 2014, corresponding to a rate of 37 cases per 100,000 population. ...More
    April 14, 2016 Posted in News
  • Biomarker Discovery Offers Hope for New TB Vaccine
    A team of scientists led by Oxford University has made a discovery that could improve our chances of developing an effective vaccine against tuberculosis (TB). The researchers have identified new biomarkers for tuberculosis which have shown for the first time why immunity ...More
    April 12, 2016 Posted in News
  • Promising New Method Inhibits TB-causing Bacteria
    Scientists at the University of Queensland and the University of California San Francisco have found a new way to inhibit the growth of the bacterium that causes tuberculosis (TB). UQ School of Chemistry and Molecular Biosciences deputy head professor James De Voss said the ...More
    April 6, 2016 Posted in News
  • New Drug Combinations Could Significantly Improve Tuberculosis Treatment
    Researchers from UCLA and Shanghai Jiao Tong University have made an important step toward a substantially faster and more effective treatment for tuberculosis, which infects some 10 million people and causes 1.5 million deaths each year. Combination therapy, which utilizes ...More
    March 29, 2016 Posted in News
  • Collection of TB-Focused Articles is Offered
    In recognition of World TB Day 2016, BMC Medicine and BMC Infectious Diseases have launched an article collection in collaboration with the UCL-TB Center and the LSHTM TB Centre, guest edited by Ibrahim Abubakar, Helen Fletcher, Marc Lipman and Tim McHugh. The collection ...More
    March 25, 2016 Posted in News
  • Clogged-up Immune Cells Help Explain Smoking Risk for TB
    Smoking increases an individual's risk of developing tuberculosis (TB) - and makes the infection worse - because it causes vital immune cells to become clogged up, slowing their movement and impeding their ability to fight infection, according to new research published in ...More
    March 25, 2016 Posted in News
  • A New Method of Viewing TB Bacteria
    Although tuberculosis (TB) is commonly thought of as being a disease that mainly affects nineteenth century poets and Victor Hugo characters, it is still the second-most common cause of mortality from an infectious disease in the world, killing nearly three people every ...More
    March 25, 2016 Posted in News
  • WHO Calls on Countries to Unite to End Tuberculosis
    On World TB Day, observed on March 24, 2016, the World Health Organization (WHO) is calling on countries and partners to "Unite to End Tuberculosis." The call comes as we enter the era of the Sustainable Development Goals (SDGs). Ending tuberculosis (TB) by 2030 is a target ...More
    March 24, 2016 Posted in News